Making the connection between family planning and global sustainability.

WCG is an international non-profit organization committed to empowering, educating and enabling women and girls to make informed choices and access critical reproductive health products and services. WCG’s credentials in product introduction have made it a preferred partner of organizations looking to move products from laboratories and manufacturing plants to the women who need them. WCG excels at forming strategic partnerships to introduce and create access to new contraceptive methods around the world. WCG’s quality and regulatory departments are experienced in the global registration of drugs and devices, and in aiding manufacturers to improve their processes to meet international best practices. We create options for women when it comes to their reproductive health — no matter where they live.

Mission

Empower and enable women and girls to make informed choices about their reproductive and sexual health.

Our Leadership

WCG’s senior leadership team & board members share an unwavering commitment to women’s reproductive health information and access. As a woman-led organization, WCG is dedicated to ensuring that women around the world, regardless of location or socio-economic status have access to reproductive health solutions.

Meet the team

Shannon Bledsoe, Executive Director

Shannon Bledsoe is the Executive Director of WCG. She is responsible for leading overall organizational growth and strategic direction, and overseeing the quality of WCG’s programming. Ms. Bledsoe brings 20 years of experience in international development, public health and reproductive rights to this role, leading programs and platforms for both large and small global non-profit organizations. She has designed and managed initiatives supporting women’s reproductive health worldwide. he has an advanced degree from the University of Melbourne, Australia and a BA from the University of California, San Diego.

Kelly Culwell, Chief Medical Officer

Dr. Culwell, the Chief Medical Officer of WCG, is also a Volunteer Assistant Clinical Professor in the Department of Obstetrics and Gynecology at the University of California, Davis and San Diego campuses. She previously served as a Medical officer with the World Health Organization, is widely published in peer reviewed journals and has developed global guidelines for clinical practice during her over 15-year career in women’s health. +

Dr. Culwell received a Bachelor’s of Science from California Lutheran University, a Medical Doctorate from the University of California, Davis and a Masters of Public Health from Northwestern University. She completed her post-graduate training in Obstetrics and Gynecology at University of California San Diego and her Family Planning Fellowship at Northwestern University. She is qualified as a Diplomat from the American Board of Obstetrics and Gynecology.

Fil Buenviaje, Director of Quality Assurance

Fil Buenviaje has worked in Quality Assurance and Regulatory Affairs for more than 20 years with leadership roles in both the Medical Device and Pharmaceutical industries.   He joined WCG Cares in 2015 and is responsible for ensuring supplier quality, product quality and global regulatory compliance with relevant laws, rules and regulations. This includes Quality Management Systems, Good Manufacturing Practices, Regulatory Compliance, and Post-Market Surveillance. +

Prior to joining WCG Cares, Mr. Buenviaje served in a variety of Quality and Regulatory roles most recently as Director of Quality Assurance at Sequenom Biosciences.  He brings with him extensive experience as a Quality/Regulatory leader supporting development, manufacturing, quality and regulatory activities from his tenure at firms:  Quidel, Biosite, Genzyme Diagnostics and TÜV Product Service.  Mr. Buenviaje has achieved certifications as a European Notified Body Medical Auditor, a Canadian Medical Devices Conformity Assessment Systems (CMDCAS) Qualified Person, ISO 9001 and ISO 13485 Lead Auditor and Regulatory Affairs Certification (RAC-US).  He has also successfully obtained product registrations with U.S., Canada, European, Asia and Latin America regulatory authorities.

Wilberto Robles, Sr. Director of Global Regulatory Affairs

Wilberto has over sixteen years of professional experience in the pharmaceutical, medical device and cosmetic industry with a special focus in reproductive health products. He holds a Bachelor’s of Science in Microbiology and a Master’s in Manufacturing Competitiveness/Industrial Engineering.  +

Wilberto previous experience includes different positions at Wyeth, Bristol-Myers Squibb, APP Pharmaceuticals and Blu Pharmaceuticals.  In these, he focused his professional experience in Regulatory Affairs, where he held different leadership positions working with International, EU, LAC and US registrations; Quality Assurance, Validations, and Project Management.  Mr. Robles has publications in the TOPRA International Journal for Professionals in Regulatory Affairs (Regulatory Rapporteur) and the POLITECHNÊ journal and SHPE (The Official Magazine of the Society of Hispanic Professional Engineers).  He is an active member of the Regulatory Affairs Professionals Society (RAPS), and The Organization for Professionals in Regulatory Affairs (TOPRA).  Mr. Robles is currently working for WCG as the Senior Director of Global Regulatory Affairs, in which he expanded his scope and manage the registrations of drug products and medical devices in more than 120 countries (mostly in Africa, Asia, and Latin America).



Noxolo Magubane, Sr. Global Regulatory Affairs Specialist

Noxolo joined WCG in 2014 and she is currently working as the Sr. Global Regulatory Affairs Specialist where she is part of the Global Regulatory Affairs team and supports the registration of medical devices and drug products primarily in Africa.  Noxolo has over 7 years of experience in Regulatory Affairs field particularly in the registration of medical devices, biological and pharmaceutical products across the African region.   She holds a Post-Graduate Diploma in Pharmaceutical Medicine from Stellenbosch University and a Bachelor of Science degree in Biochemistry and Microbiology from the University of Kwa-Zulu Natal. +

She began her career at Quintiles as a Clinical Research Apprentice.   In 2012, she joined Sanofi Pasteur as a Medical and Regulatory Affairs Associate, the main responsibilities for that role included drug safety and pharmacovigilance and various Regulatory Affairs activities such as clinical trial registrations, product registrations and submission of post-approval amendments and label updates in South Africa and various SADC countries.  She is an active member of the Southern Africa Pharmaceutical Regulatory Affairs Association (SAPRAA), Regulatory Affairs Professionals Society (RAPS) and the Organization for Professionals in Regulatory Affairs (TOPRA).  Noxolo has a publication in the TOPRA International Journal for Professionals in Regulatory Affairs (Regulatory Rapporteur).

Kate Morrison, Program Manager

Kate has eight years of experience in clinical research, survey design, quantitative and qualitative data collection and analysis, monitoring and evaluation, and working collaboratively and cross-culturally in low-resource environments. She joined WCG in 2014 to support the MAX program and currently is a Program Manager for a USAID-funded Grand Challenges project and new business development. Ms. Morrison received a Bachelor’s of Science in Physiology from UCLA and a Master of Public Health in Maternal and Child Health & International Health from Boston University.

 

 

Courtney Stachowski, Program Manager

Courtney joined WCG Cares as a Program Manager in 2016 and currently works in the Regulatory Affairs department. Courtney has eight years of experience working in the field of public health in both clinical and academic research capacities focusing on sexual and reproductive health, infectious diseases, and health systems research. Courtney has a B.A. from Bates College in Sociology and an MPH from Emory University in International Health / Sexual and Reproductive Health and Population Studies.

Danielle Harris, Program Manager

Danielle joined WCG Cares as a Program Manager in April 2018, and manages a portfolio of projects piloting the introduction of new and improved contraceptive methods in sub-Saharan Africa and the Caribbean. Danielle has an extensive background in managing international and domestic research projects focusing on maternal and child health as well as HIV prevention and treatment. Danielle holds a B.A. in International Relations and Spanish from Virginia Tech, an M.P.H. in Community Health Sciences and an M.A. in African Studies from the University of California, Los Angeles.

Erica Chavin, Director of Finance

Erica joined WCG in February 2018 as the Accounting Manager, then transitioned to the Director of Finance in October. She has over 15 years experience working in the non-profit industry; most recently, serving as the Director of Finance, Sponsored Research and Administration at The Scintillon Institute in San Diego. Previously, Erica was a Senior Grant and Contract Administrator for La Jolla Institute for Allergy & Immunology and also spent several years as a Supervisor in the Office of Sponsored Programs at The Scripps Research Institute and a Financial Advisor at Merrill Lynch.  In these roles, Erica was recognized for implementing solution-based strategies, improving processes and supporting business operations. Erica has a Bachelor of Science degree in Economics from Cal Poly San Luis Obispo and is an Enrolled Agent.

Matthew DeVol, Finance Specialist

Matthew has over 30 years of experience in accounting and financial management, and has executive-level experience in 501(c)3 organizations. Prior to joining WCG, Matthew worked as the Senior Director, Finance & Grants Administration for the La Jolla Institute for Allergy and Immunology. He has worked with San Diego by Project Concern International, furthering his work with USAID-funded international organizations on maternal and child healthcare, sanitation, water, and other donor-supported programs, prior to moving into the non-profit biotech field. Matthew is a certified C.P.A.

James Trussell, PhD - Chair

Dr. James Trussell joined the WCG Board of Directors in December 2016. Dr. Trussell is Professor Emeritus of Economics and Public Affairs and Senior Research Demographer of the Office of Population Research at Princeton University. He is also an Honorary Fellow at the University of Edinburgh. Dr. Trussell is the author or co-author of more than 350 scientific publications, primarily in the areas of reproductive health and demographic methodology. +

His recent research has been focused in 3 areas: emergency contraception, contraceptive failure, and the cost-effectiveness of contraception. Dr. Trussell received his BS in mathematics from Davidson College in 1971, a BPhil in economics from Oxford University in 1973, and a PhD in economics from Princeton University in 1975. He is a Senior Fellow at the Guttmacher Institute and a Deputy Editor at Contraception.

Jill Sheffield

Jill Sheffield is the founder of Women Deliver, an international advocacy organization that convenes global leaders to galvanize action on maternal health and women’s empowerment. Most recently, Ms. Sheffield was one of few civil society representatives appointed to the UN Secretary General’s Commission on Information and Accountability for Women’s and Children’s Health. Ms. Sheffield is the Chair of the FIGO Working Group on Contraception, serves as a Senior External Adviser to the IPPF Governing Council, and is on the Board of PPFA/Global. She is also a consultant/senior adviser to Global Health Strategies on reproductive health and choices.

+

Ms. Sheffield is also the founder of Family Care International (FCI), a distinguished non-governmental organization and winner of the 2008 United Nations Population Award for outstanding work in sexual and reproductive health and rights. Ms. Sheffield completed advanced degrees at Columbia University, Teachers College, where she was later recognized as a distinguished alumna for her international work in women’s health and education, and she also received the American Public Health Association’s Lifetime Achievement Award in 2008. She was Director of International Programmes at the Carnegie Corporation, and founded FCI in 1987 in response to the call at the Women’s Decade Conference in Nairobi which identified the silent tragedy that one woman dies each minute from pregnancy related causes. Though she has played a central role in several key world conferences, Jill Sheffield believes her true education came in the late 1960s when she worked in Nairobi, Kenya’s Pumwani Hospital in the first family planning/reproductive health outpatient clinic opened in East Africa.

 

Saundra Pelletier

Saundra Pelletier is the founding CEO of WCG and she also is the CEO of Evofem Biosciences, a clinical-stage biopharmaceutical company committed to developing and commercializing innovative healthcare products to address unmet needs in women’s sexual and reproductive health. Ms. Pelletier has extensive private sector experience in leadership, sales, domestic and international marketing, business development and life cycle management for a variety of women’s healthcare products including contraceptives, vaginal infectives, hormone replacement therapies and fertility treatments.